Form 4: Biohaven Director Julia Gregory Receives Stock Options
Statement of Changes in Beneficial Ownership
Director Julia P. Gregory was granted 68,693 stock options in Biohaven Ltd. as part of an equity compensation arrangement.
Summary
- Director Julia P. Gregory received a grant of 68,693 stock options on April 28, 2026.
- The options have an exercise price of $9.61 per share.
- The options are set to expire on April 28, 2036.
- The grant is subject to a vesting schedule tied to the earlier of April 28, 2027, or the 2027 Annual Meeting of Shareholders.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation that does not signal a change in company strategy or financial health.
Positives
- Alignment of director interests with long-term shareholder value through equity-based compensation.
Negatives
- The grant results in potential future dilution for existing shareholders upon exercise.
Risks
- Market price volatility may impact the value of the options relative to the exercise price.
- Vesting is contingent upon the director's continuous service with the issuer.
Future Outlook
The options vest in full on April 28, 2027, or the date of the 2027 Annual Meeting of Shareholders, provided the director remains in service.
Industry Context
StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice in the biotechnology sector to ensure board members are incentivized to oversee long-term strategic growth.
Comparison to Industry Standards
- The grant of stock options to directors is consistent with standard compensation packages for mid-cap biotechnology firms.
- The one-year vesting period is a common practice for annual director equity awards.
Stakeholder Impact
- Minor dilution impact on existing shareholders upon future exercise of options.
Next Steps
- Vesting of options on April 28, 2027, or the 2027 Annual Meeting of Shareholders.
Key Dates
| Date | Description |
|---|---|
| 04/28/2026 | Date of grant and earliest transaction. |
| 04/28/2027 | Vesting date for the stock options. |
| 04/30/2026 | Date of filing. |
| 04/28/2036 | Expiration date of the stock options. |
Keywords
Biohaven, BHVN, Form 4, Director Compensation, Stock Options, Insider Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.